Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients

NCT04088318 is registered in ClinicalTrials.gov with OnQuality Pharmaceuticals (USA) LLC as lead sponsor.

NCT NCT04088318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Lead sponsor
OnQuality Pharmaceuticals (USA) LLC
Phase
Phase 2
Overall status
Unknown status
Start date
December 9, 2019
Completion date
June 30, 2024
Enrollment
170 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hand-foot skin reaction (hfsr)